• Japanese
  • Korean
  • Chinese
Cover Image

Contraceptives

Product Description

This report analyzes the worldwide markets for Contraceptives in US$ Million by the following Product Segments: Oral Contraceptives, Condoms, Implants/ Injections, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 123 companies including many key and niche players such as Ansell Limited, Condomi Health International GmbH, Bayer HealthCare Pharmaceuticals, Church & Dwight Co. Inc., Conceptus, Inc., Female Health Company, Fuji Latex Co Ltd., HLL Lifecare Limited, Johnson & Johnson, Janssen Pharmaceuticals Inc., Merck & Co., Inc., Okamoto Industries, Inc., Reckitt Benckiser Group Plc, Teva Pharmaceutical Industries Limited, Warner Chilcott plc, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Oral Contraceptives
  • Condoms
  • Implants/Injections
  • Other Contraceptives

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Primer
  • Contraceptives Market: Quick Facts
  • Outlook
  • Growth Drivers
  • Challenges
  • Impact of Recession: An Unequivocal Review
  • Cooling Economy Induces Changes in Childbearing Trends
  • Recession Adds Fuel to Cost/Affordability Challenge
  • Rising Preference for Surgical Family Planning Procedures
  • Contraceptives among Women: Scenario in the Developing World
    • Table 1: Contraceptives Market in Developing World (2012): Percentage Breakdown of Unintended Pregnancies by Contraceptive Usage Trend (includes corresponding Graph/Chart)
    • Table 2: Capability of Modern Contraception in Mitigating Mortality by Unintended Pregnancies in Developing Countries (2012) (includes corresponding Graph/Chart)
  • Other Trends & Issues
  • Consolidation to Guide New Entrants into the Contraceptives Market
  • Increasing Awareness Over STDs to Create Additional Demand for Condoms
    • HIV Prevalence and Incidence Statistics
    • Table 3: Global Prevalence of HIV Infection in 2010 by Region (in Millions) (includes corresponding Graph/Chart)
    • Table 4: Newly Infected HIV Population in 2010 by Region (in Millions) (includes corresponding Graph/Chart)
    • Table 5: Global HIV Related Deaths in 2010 by Region in Millions (includes corresponding Graph/Chart)
    • Table 6: Global HIV Prevalence among Adults and Youth (Male and Female) By Region: 2010
  • Multifunctional Modern Contraceptives Make a Foray
  • Skin Sprays: A Novel Way of Contraception
  • Extensive Distribution Drives growth of Contraceptive Products
  • Public Health Organizations Spur Condoms Use
  • USAID Worldwide Shipments of Condoms and Other Contraceptives
    • Table 7: USAID Shipments of Condoms and Contraceptives Worldwide (2011): Percentage Share Breakdown of Unit Shipments by Type - Male Condoms, Female Condoms and Oral Contraceptives
    • Table 8: USAID Shipments of Condoms and Other Contraceptives Worldwide (2010): Percentage Share Breakdown of Value Shipments by Region -Africa, Asia/Near East, Caribbean/Latin America and Europe/Eurasia (includes corresponding Graph/Chart)
    • Table 9: Global USAID Shipments of Condoms and Other Contraceptives (2010): Percentage Share Breakdown of Value Shipments by Type -Condoms, Injectables, Orals, Implants and IUDs (includes corresponding Graph/Chart)
    • Table 10: USAID Shipments of Condoms and Other Contraceptives Worldwide (2010): Percentage Share Breakdown of Value Shipments by Program Type -Parastatal/Governmental, Social Marketing, NGO and Research (includes corresponding Graph/Chart)
  • Latex Supply Woes Impact the Condoms Market
  • Advertising for Contraceptives Acquires A Whole New Dimension
  • Emergency Contraception Receives Encouragement from Government
  • Manufacturers & Retailers Work in Sync to Accelerate Sales
  • Competition in the Contraceptives R&D Market to Intensify
    • Table 11: Global Contraceptives Market (2010): Percentage Breakdown of Product Share in the R&D Pipeline by Stage of Clinical Trial (includes corresponding Graph/Chart)
  • Innovation Keeps the Fire Burning for the Condoms Market
  • Generic & Biosimilar Contraceptive Products Gain Ground
  • Generics Manufacturers
  • OTC Hormonal Contraceptives - An Attractive Market
  • Oral Contraceptives - A Painless Panacea for Prevention of Unwanted Pregnancy
  • R&D Companies & Generic Manufacturers - Developing Countries
  • Commercial Success of R&D Brands Sustain Developmental Programs in Developing Countries
  • Challenges Facing Generic Contraceptive Products Manufacturers

2. PRODUCT OVERVIEW

  • Types of Contraception
  • The Contraceptive Timeline
  • By Function
    • Barrier Contraceptives
      • Characteristic Features of Barrier Methods
    • Hormonal Contraceptives
      • Prescription Contraceptives
      • Oral Contraceptives
      • Overview of Oral Contraceptives - Benefits vs. Risks
      • Usage Levels of OCs in Worldwide Scenario
      • Traditional and Modern
      • Reversible and Permanent
      • Birth Control Methods and their Use in Major Regions Worldwide
      • Contraception - Levels of Effectiveness
      • Effectiveness Index of Contraceptive Measures
      • Unmet Need for Contraception
  • Segmental Analysis
  • A. Condoms
      • Overview
      • Categories
      • Latex Condoms
      • Non-Latex Condoms
      • Skin Condoms
      • Polyurethane (PU) Condoms
      • Comparison Between Polyurethane & Latex Condoms
      • Male Condom - Effectiveness of Protection Against STDs
      • Myths & Facts
      • Selection & Effective Use of Condoms
      • Highlights
      • Growth Factors
      • Factors Hindering Wide Spread Use of Condoms
      • Measures Aimed at Increasing Usage
      • Female Condoms
      • Who are the Main Users?
      • Reality - An Effective Female Condom
  • B. Oral Contraceptives (OCs)/Pills
      • A Peep into the Past
      • Synthetic Oral Contraceptives
      • Characteristic Features of Oral Contraceptives (OCs)
      • Bayer Schering Pharma's "Yasmin": A Resounding Brand Worldwide
      • Advantages of Using OCs
      • Effects of Long-Term Use of OCs
      • Use of OCs/Pills - Myths & Facts
      • Oral Contraceptives - Challenges & Strategies to Overcome Problems
      • Factors Associated with Failure of OCs/Pills
      • Health Conditions to be Addressed when Using OCs
      • Understanding Risks Associated with Use of OCs
      • Cardiovascular Disease - A Major Side Effect of OCs
      • Intake of OCs Result in High Blood Pressure
      • Smoking Intensifies Respiratory Problems in Pill Users
      • Age Related Complications Associated with the Direct Use of OCs
      • Relation Between OC and Cancer
      • Depression Linked to Use of OCs
      • OCs Increases Osteoporosis Risk at Later Stage
      • OCs May Reduce Sex Drive
      • Effects of Pill on Childbearing Capacity
      • Visiting a Doctor - Highly Recommended in Case of Warning Symptoms
      • Emergency Contraception (EC) - A New Face of OCs
      • Role of ECPs
      • Effectiveness of ECP
      • Different Types of EC Products
      • Mini Pills
      • RU486 - the French Abortion Pill
      • Availability of Hormonal Contraceptives as OTC Drugs
  • C. Injectable Contraceptives
      • Depo-Provera
      • Characteristic Features of Injectable Contraceptives
      • Injectables - Challenges & Strategies to Overcome Problems
  • D. Intrauterine Devices (IUDs)/Implants
      • Product Categories
      • CopperT 380A (ParaGard)
      • Progesterone T (or Progestasert)
      • Characteristic Features
      • Benefits
      • Side Effects
      • Challenges & Strategies to Overcome Problems
      • Long-term Reversible Contraceptive Implants
      • Products
      • Norplant
      • Implanon
      • Mirena
      • Characteristic Features of Implantable Contraceptives
      • Challenges & Strategies to Overcome Problems
  • E. Spermicides
      • Product Categories
      • Benefits
      • Drawbacks
      • Contraceptive Foam
      • Delfen Contraceptive Foam
      • Contraceptive Cream or Jelly
      • Encare Ovals
    • Table 12: Effectiveness in Prevention of Pregnancy - Condom and Spermicide, Condom Alone and Spermicide Alone (includes corresponding Graph/Chart)
  • F. Diaphragms
  • G. Withdrawal & Douching
  • H. Sterilization
      • Tubal Ligation
      • Reasons Behind Adoption
      • Risk of Complications
      • Types
      • Abdominal Procedures
      • Laparoscopy
      • Mini-Laparotomy
      • Laparotomy
      • Vaginal Procedures
      • Culdoscopy
      • Colpotomy
      • Hysterectomy - A High Risk Surgery
      • Selective Tubal Occlusion Procedure (STOP)
      • Vasectomy
      • Method of Working
      • Reasons Behind Adoption
      • Risk of Complications
  • I. Other Contraceptive Methods
      • Contraceptive Sponges
      • Today Sponge
      • Characteristic Features of Today Sponge
    • Table 13: Efficiency Rates of Today Sponge Based on Usage for 12-Month Period (includes corresponding Graph/Chart)
      • Protectaid Sponge
      • Characteristic Features of Protectaid Sponge
      • Cervical Caps
      • Pros and Cons of the Device
      • Vaginal Contraceptive Film (VCF)
      • Contraceptive Vaccine
      • Ortho Evra Weekly Contraceptive Patch
      • NuvaRing Monthly Vaginal Ring

3. RESEARCH AND DEVELOPMENT

  • Oral Contraceptive Minimizes Premenstrual Syndrome Symptoms as per New Study
  • Cause of Infertility - Not Associated with IUDs
  • Presence of Estrogen in OCs Offers Protection from Colorectal Cancer
  • Hormonal Contraceptive Usage & Risk Associated with Certain STDs
  • Use of Third Generation Ocs Increases Risk of Blood Clots
  • High Risk of Deep Vein Thrombosis with Cyproterone- Containing OCs

4. ROLE OF UNITED NATIONS IN PROMOTING USE OF CONTRACEPTIVES

  • Female Condoms Reach New Heights with Aid from UNAIDS
  • Donor Support for Contraceptive Commodity
    • Table 14: Total Cost of Contraceptives and Condoms: 2000-2010 (In US$ Million) (includes corresponding Graph/Chart)
  • Unmet Need
  • Urgent Need for Use of Modern Contraceptives
    • Table 15: Penetration of Modern Contraceptives in Developing Regions for Women in Reproductive Age by Need (2011) (includes corresponding Graph/Chart)
    • Table 16: Usage of Modern Contraceptive by Women in Developing Countries (2012): Percentage Breakdown by Type (includes corresponding Graph/Chart)
  • Use of Modern Contraceptives Grows in Developing Regions
    • Table 17: Estimated Numbers of Contraceptive Users in Developing Nations: 2000-2015 (In Millions) (includes corresponding Graph/Chart)
    • Table 18: Percentage Penetration of Modern Contraceptives by Married Women by Region/ Country (2011) (includes corresponding Graph/Chart)
    • Table 19: Capability of Modern Contraception in Mitigating Mortality by Unintended Pregnancies in Developing Countries (2012) (includes corresponding Graph/Chart)
  • Difference in Usage of Oral contraceptives in Developed and Developing World
  • Prevalence of Contraceptive Methods
    • Table 20: Worldwide Contraceptives Market: Estimated Number of Users (2015 & 2025) - Asia, Latin America and Africa (In Millions) (includes corresponding Graph/Chart)
    • Table 21: Worldwide Contraceptive Market: Prevalence in Women (2000-2025) - Percentage Share by Asia, Latin America and Africa (includes corresponding Graph/Chart)
  • United Nations Population Fund (UNFPA)
  • UNFPA Gets Aid from Britain to Help Developing World
  • Rise in Cost of Providing Contraceptives
  • Future Trends Worldwide

5. NEW PRODUCT INTRODUCTIONS/ INNOVATIONS

  • Watson Pharmaceuticals Introduces Vestura an Oral Contraceptive
  • Ansell Unveils SKYN(r) Condom in Brazil and China
  • Vystar(r) and Ritex Gummiwarenfabrik to Launch Ritex Silver-Light Condoms
  • Bayer HealthCare Pharmaceuticals Introduces Qlaira(r) Oral Contraceptive
  • The Female Health Offers La Luna Female Condoms in Israel
  • Merck & Co Introduces NEXPLANON 68mg
  • Watson Pharmaceuticals Introduces Generess(tm) Fe
  • WomanCare Global Includes Essure(r) to Product Portfolio
  • LifeStyles Introduces SKYN(r) Large
  • Acme Brasil Introduces Condoms under the Unique by Natural Sensation(r)
  • Conceptus Launches Essure FlexPayTM Financial Assistance Plan
  • Lupin Pharmaceuticals Introduces Generic Femcon Fe Chewable Tablets in US
  • Hyundai Pharm and HRA Pharma Roll Out ellaOne in South Korea
  • Futura Develops CSD500

6. PRODUCT INNOVATIONS/INTRODUCTIONS IN THE RECENT PAST - A PERSPECTIVE BUILDER

  • Watson Pharmaceuticals Rolls Out ella Oral Emergency Contraceptive
  • HLL Lifecare to Launch Pan Flavoured Condoms
  • Glenmark Generics Receives USFDA Approval for Norethindrone Tablets
  • HLL Lifecare to Introduce Moods in Australian Markets
  • Organon Releases Contraceptive NuvaRing
  • HRA Pharma Unveils ellaOne
  • Bayer Introduces Qlaira New Oral Contraceptive
  • Durex Introduces Avanti Bare(tm)
  • Teva to Introduce Tri-Lo Sprintec
  • Teva Announces Launch of Topiramate Tablets
  • Duramed Releases LoSEASONIQUE
  • Uganda Health Marketing Group Rolls Out NewFem, A New Contraceptive Pill
  • TTK LIG to Unveil Durex Jeans Condoms
  • Teva Pharmaceutical Industries Receives Approval for Plan B One-Step Emergency Contraceptive
  • Cupid Limited to Unveil Cost-effective Female Condoms
  • Bayer Schering Pharma Launches QlairaA(r)
  • Watson Laboratories Secures USFDA Approval for Plan B OTC Generics
  • Organon Launches Vaginal Contraceptive Ring

7. RECENT INDUSTRY ACTIVITY

  • Ansell Takes Over Trelleborg Protective Products Operations
  • Bayer HealthCare Partners with USAID to Launch Microgynon Fe Contraceptive
  • DKT International to Distribute Contraceptives in Ghana
  • Conceptus Obtains FDA Approval for Inclusion of 10-Year Data for Essure(r) Procedure
  • Conceptus Secures FDA Approval for Label Changes Related to Compatible Usage of NovaSure(r) with Essure
  • Lupin Receives FDA Approval for Generic Variant of Ortho Tri-cyclen Lo Oral Contraceptive
  • Glenmark Generics US Receives FDA Approval for Ethinyl Estradiol and Norgestimate Tablets
  • Bayer HealthCare Pharmaceuticals Receives FDA Approval for NataziaTM
  • Teva Receives FDA Approval for Quartette(tm), An Oral Contraceptive for Females
  • Agile Therapeutics Receives FDA Approval for AG200-15, Contraceptive Patch
  • The Female Health Company Established Two New Production Lines In Malaysia
  • Glenmark Receives Approval for its Viorele, an Oral Contraceptive for Women
  • Watson Pharmaceuticals Receives USFDA Approval for Beyaz
  • Bayer Files for EU Approval for the Company's Birth Control Patch
  • J&J 's Ortho Evra, Birth Control Patch Receives FDA Approval
  • Pfizer Recalls Norgestrel/Ethinyl Estradiol Tablets and Lo/Ovral(r)-28 Tablets from US
  • Savanna East Africa Acquires Kenyan Condom Producer in Kenya
  • Ansell Takes Over Minority Stake in Yulex
  • Ortho-McNeil and PriCara to Operate Under Janssen Pharmaceuticals
  • Conceptus Acquires Distribution Rights to Essure Device
  • Sosei Receives Approval for NorLevo Tablets by Japan Ministry of Health, Labour and Welfare
  • Starpharma Holdings Inks Licensing Agreement with Ansell
  • Starpharma Holdings Enters into Agreement with Okamoto
  • Female Health Company Receives Supply Order from British Government

8. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER

  • WomanCare Global Acquires Roselle and Optinor from Icon
  • Teva Signs Deal to Acquire Theramax
  • Ferring Pharmaceuticals Purchases Lysteda from Xanodyne Pharmaceuticals
  • NextPharma Technologies Expands Waltrop Semi-Solids Hormones Facility
  • Reckitt Benckiser Acquires SSL International
  • Warner Chilcott and Lupin Pharmaceuticals Ink Settlement Agreement
  • FHC Bags Order to Supply 3.5 Million FC2 Female Condoms for 2010 World Cup in South Africa
  • SSL Acquires Majority Stake in BLBV
  • Columbia Laboratories Inks Definitive Agreement with Watson Pharmaceuticals
  • Piramal Healthcare Signs Definitive Agreement with Cipla
  • Watson Pharmaceuticals to Market HRA Pharma's Emergency Contraceptive
  • Lupin to Establish Three New Production Facilities
  • Pfizer to Purchase Wyeth
  • Ansell Healthcare Signs Agreement with NYC Department of Health and Mental Hygiene
  • Teva Pharmaceutical Industries' Yaz Receives FDA Approval
  • Teva Pharmaceutical Industries' Yaz Receives Marketing Approval from FDA
  • Watson Pharmaceuticals, Warner Chilcott Collaborate for Femring
  • Watson Pharmaceuticals Inks Agreement with Warner Chilcott for WC3026
  • Merck Merges with Schering-Plough
  • Vystar Inks Agreement with Centrotrade Minerals and Metals and Centrotrade Deutschland
  • Mayer Laboratories Signs Agreement with Alvogen Group
  • Hypermarcas Acquires Inal
  • Sosei Inks Distribution Agreement with ASKA Pharmaceuticals
  • Sanofi-Aventis to Construct Plant in Brazil
  • Durex Chinese Plant Starts Production
  • Patheon Expands Toronto Plant
  • Female Health Co Receives FDA Approval for Cheaper Female Condom

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Ansell Limited (Australia)
  • Condomi Health International GmbH (Germany)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Church & Dwight Co., Inc. (US)
  • Conceptus Inc (US)
  • Female Health Company (US)
  • Fuji Latex Co Ltd (Japan)
  • HLL Lifecare Limited (India)
  • Johnson & Johnson (US)
  • Janssen Pharmaceuticals Inc. (US)
  • Merck & Co., Inc (USA)
  • Okamoto Industries Inc (Japan)
  • Reckitt Benckiser Group Plc (UK)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Warner Chilcott plc (Ireland)
  • Pfizer Inc (USA)

10. GLOBAL MARKET PERSPECTIVE

    • Table 22: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 25: World Recent Past, Current & Future Analysis for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 27: World 15-Year Perspective for Oral Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 30: World 15-Year Perspective for Condoms by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Implants/Injections by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Implants/Injections by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 33: World 15-Year Perspective for Implants/ Injections by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Other Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Other Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 36: World 15-Year Perspective for Other Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Restraints
    • Are Women's Reproductive Rights Getting Axed on the New Health Care Bill?
    • Medicaid Coverage For Family Planning
    • Regulations Encouraging Access to Emergency Contraceptives
    • Major Market Trends
      • Generics Pitted Against Branded in the Oral Contraceptives Market
      • Changing Consumer Demographics
      • Relentless Promotional Programs Drive Home the Point
      • Use of Intimacy Products on the Rise
      • Generics Ransack the Branded Market
      • Condoms - A 'Fun, Inviting and Pleasurable' Way to Healthy Life and Lifestyle
    • Market Share Statistics
    • Table 37: Leading Players in the US Male Contraceptives Market (2011): Percentage Breakdown of Sales for Church and Dwight Co., Reckitt Benckiser, Ansell, Global Protection, Mayer Labs, Majestic Drug Co., Private label and Others (includes corresponding Graph/Chart)
    • Table 38: US Market for Condoms by Leading Players (2011): Market Share Breakdown for Church & Dwight, Reckitt Benckiser, Ansell America, and Others (includes corresponding Graph/Chart)
    • Table 39: Leading Brands in the US Condom Market (2011): Percentage Share Breakdown by Sales (includes corresponding Graph/Chart)
    • Table 40: US Condoms Market: Percentage Breakdown of Dollar Sales by Product Type for the Year Ended January 2006 (includes corresponding Graph/Chart)
    • Table 41: Leading Female Contraceptive Manufacturers in the US (2011): Percentage Breakdown of Market Share for Duramed Pharmaceuticals, Watson Pharmaceuticals, Coldwell Consumer Health, Apothecus and Others (includes corresponding Graph/Chart)
    • Table 42: Leading Brands in the Female Contraceptives Market in the US (2009): Percentage Breakdown of Market Share for Plan B, VCF, Ortho Options Conceptrol, Encare, Ortho Options Gynol II and Others (includes corresponding Graph/Chart)
    • Noticeable Shift in Retail Marketing Techniques
    • Rising Use of Condoms Amongst Teenagers
    • Changing Attitudes and Perceptions Drive Market Sales
    • Table 43: Contraceptive Usage (Methods) and Non-Usage among Women Aged 15-44 Years in the US (2011) (includes corresponding Graph/Chart)
    • Elimination of Co-pays to Boost Contraceptive Sales
    • Pill Continues to be One of the Most Popular Forms of Contraception
    • Table 44: Usage Trends of Select Contraceptive Methods Among Women Aged 15-44 Years in the US (2011): Percentage Breakdown by Marital Status (includes corresponding Graph/Chart)
    • Table 45: Female Contraception in the US (2011): Percentage Breakdown of Usage of Pill or Sterilization Method by Age Group (includes corresponding Graph/Chart)
    • Table 46: Leading Birth Control Pill Brands in the US (2011): Percentage Breakdown of Market Share for Yaz, Tri-Sprintec, Ocella, Loestrin 24 Fe, NuvaRing, Sprintec, Trinessa, Aviane, Ortho Tri-Cyclen Lo and Others (includes corresponding Graph/Chart)
    • Oral Contraceptives Gain Ground in the US
    • Table 47: Leading Birth Control Pill Manufacturers in the US (2010): Percentage Breakdown of Market Share for Duramed Pharmaceuticals, Watson Pharmaceuticals Inc., Caldwell Consumer Health L.L.C., Apothecus Inc. and Others (includes corresponding Graph/Chart)
      • Oral Contraceptives and its Shades of Grey
      • Marketing Efforts Aimed at Influencing Female College Students
    • Condoms Continuing Canter
    • Drug Stores Remain the Choice for Contraceptive Needs
    • Trade Class Statistics
    • Oral Contraceptives - Unanimously the Choice of American Women
    • Table 48: Contraceptive Features Preferred by Women in US (includes corresponding Graph/Chart)
      • Health Facts
      • Rising Use of Oral Contraceptives
    • Abortion Control Drugs & Methods
      • Medical Abortion
      • a. Mifepristone - A Medical Breakthrough
      • b. Methotrexate
      • Expanding the Use & Availability of EC Drugs
      • Pharmacies Sell ECPs
    • Demographics
      • Facts and Figures
      • Sales of Contraceptives (Male & Female) - Family Planning Category
      • Insurance Coverage for Contraceptives Still in Contest
    • Strategic Corporate Developments
    • Product Innovations/Launches
    • Key Players
  • B. Market Analytics
    • Table 49: US Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 50: US Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 51: US 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Scenario
    • Outlook
    • Condoms Market
    • Immucon Obtains US Patent for Male Contraceptive Technology
  • B. Market Analytics
    • Table 52: Canadian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 53: Canada Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 54: Canadian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Market for Oral Contraceptives Yet to Take Off
      • Innovation Expected to Drive Sales
    • Major Issues and Trends
      • Domestic Products Dominate the Market
      • Health Care Institutions Remain Main Distribution Channels
    • Market Issues
      • Compulsory Labeling of Contraceptives
      • Impact of Legalization of Oral Contraceptives
      • Late Approval for Use of OCs in Japan
    • Factors Hindering Widespread Use of OCs
    • Condoms Market
    • Key Players
  • B. Market Analytics
    • Table 55: Japanese Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 56: Japanese Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 57: Japanese 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Condoms Market
    • Prejudices Pertaining to Birth Control Pills
    • Condoms and Other Contraceptives Market
    • Table 58: USAID Shipments of Condoms and Other Contraceptives to Europe and Eurasia (2010): Percentage Share Breakdown of Value Shipments by Type -Condoms, Orals, Female Condoms, IUDs and Injectables (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 59: European Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 60: European Historic Review for Contraceptives by Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 61: European 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 62: European Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 63: European Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 64: European 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • Condoms Market
  • B. Market Analytics
    • Table 65: French Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 66: French Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 67: French 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • German Women Record Highest Usage Rate of Contraceptive Pill
    • Condoms Market
    • Key Players
  • B. Market Analytics
    • Table 68: German Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 69: German Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 70: German 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 71: Italian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 72: Italian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 73: Italian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Overview
    • UK Contraceptives Market Sails Through Recession
    • Changing Societal Trends
    • Innovations: Need of the Hour
    • Availability of Contraceptives
      • Contraceptive Injections
      • Emergency Contraception (EC)
      • Barrier Contraceptives
    • Major Trends and Issues
      • Hormone Based Products Overtake Barrier Products
      • Condoms Still Find Immense Favor in Britain
    • Table 74: Condom Usage Trends in the UK (2012): Breakdown of Usage Rate by Age and Gender (includes corresponding Graph/Chart)
      • Value of Condoms Declines Even as Volume Sales Increases
      • Role of Pharmacies in Improving Availability of Condoms and EC Drugs
    • Regulatory Environment
      • CEN Standards
      • Advertising and Promotion
      • Hormone-Based Contraceptives Restricted by Legislation
  • B. Market Analytics
    • Table 75: UK Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 76: UK Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 77: UK 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Outlook
  • B. Market Analytics
    • Table 78: Spanish Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 79: Spanish Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 80: Spanish 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 81: Russian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 82: Russian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 83: Russian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Modern Contraceptives Usage in Eastern European Markets
    • Table 84: Usage Rates of Modern and Traditional Contraceptives in Developed and Developing Markets in Europe (2010)
    • Regional Briefs
      • Czech Republic
      • Denmark
      • Portugal
    • Table 85: Contraceptives Market in Portugal: Usage of Contraceptive Methods - Percentage Share by Condoms, OCs/Pill, Combination Method, Withdrawal and Calendar Method (includes corresponding Graph/Chart)
      • Poland
      • Sales of Contraceptives Plunges
      • Romania
      • A Glimpse of the Oral Contraceptives Market in Romania
    • Table 86: Leading Players in the Oral Contraceptives Market in Romania (2010): Percentage Breakdown of Value Sales for Bayer Healthcare, Gedeon Richter, Merck and Others (includes corresponding Graph/Chart)
      • Other Countries
    • Key Player
  • B. Market Analytics
    • Table 87: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 88: Rest of Europe Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 89: Rest of Europe 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Market Primer
    • Table 90: Percentage Breakdown of Number of Women in the Age group of 15-49 Years Using Modern Contraceptives in Asia for 2012 by Sub-region (includes corresponding Graph/Chart)
    • Key USAID Statistics
    • Table 91: USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Breakdown of Value Shipments by Country - Pakistan, Nepal, Bangladesh, Myanmar, Vietnam and Others (includes corresponding Graph/Chart)
    • Table 92: USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Percentage Share Breakdown of Value Shipments by Type - Condoms, Orals, Injectables, IUDs and Implants (includes corresponding Graph/Chart)
    • Table 93: USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Breakdown of Value Shipments by Program Type - Social Marketing, Parastatal/Governmental, NGO and Research (includes corresponding Graph/Chart)
    • Greater Need for Contraception Awareness Among Adolescents
    • Oral Contraceptives Hold Potential for Growth
    • Condoms Shortage Raise Fears of More HIV/AIDS Infections
  • B. Market Analytics
    • Table 94: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 95: Asia-Pacific Historic Review for Contraceptives by Geographic Region - China, India and Rest of Asia-Pacific Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 96: Asia-Pacific 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 97: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 98: Asia-Pacific Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 99: Asia-Pacific 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Overview
    • Current and Future Analysis
      • A Review of the Contraception and Birth Control Procedures in China
      • Poor Contraceptives Use Leads to Alarming Rise in Abortion Rates
      • Low Acceptance of Yaz Flex Oral Contraceptive Pill Among Women
      • Contraceptive Requirements
      • Condoms
      • 14-Year Ban on Condom Advertising Finally Lifted
      • Condoms Witness Increasing Demand
  • B. Market Analytics
    • Table 100: Chinese Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 101: Chinese Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 102: Chinese 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Overview
    • Current and Future Analysis
      • Rise in Population Fuels Growth
      • Family Planning, Need to Address Requirements
      • Pressing Need for Modern Contraceptives Awareness in India
      • Oral Contraceptives
      • Indian Women Fairly Open to the Concept of Oral Contraceptives
      • Free Distribution Scheme
    • Table 103: Percentage Breakdown of Free and Paid Condoms in India for years 2007-08 through 2011-12 (includes corresponding Graph/Chart)
      • Social Marketing Scheme
    • Table 104: Condoms Market in India (2008-2011): Percentage Breakdown of Condoms by Method of Distribution - Socially Marketed Condoms, Free Condoms and Commercially Marketed Condoms (includes corresponding Graph/Chart)
      • Other Initiatives by NACO
    • Table 105: NACO Condom Social Marketing Programme (June 2011): Sales Achievement as Compared to Sales Target (in Rs Crores) (includes corresponding Graph/Chart)
      • Global Brands Still Alien to Indians
      • Emergency Contraceptives - A Sunrise Segment
    • Table 106: Leading Players in the Emergency Contraception Market in India (2011): Percentage Breakdown of Market Share for Piramal Healthcare Ltd, Mankind Pharma Ltd and Others (includes corresponding Graph/Chart)
      • Misuse of Emergency Contraceptive - A Cause of Concern
      • Social Marketing Scheme (SMS)
      • Goli Ke Hamjoli Campaign
      • Contraceptives Distributed by Marketing Companies & NGOs Under Social Marketing Schemes
      • Condoms
      • Overview
      • Supply
      • Market Segments
      • Female Condoms Foray in Indian Market
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 107: Indian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 108: Indian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 109: Indian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • A Review of Select Markets
      • Bangladesh
      • Status of HIV Infections
      • Indonesia
      • Competition Between Subsidized and Non-Subsidized Condom Sectors Increases
      • Rise in Contraceptive Use and Decline in Fertility Characterizes Indonesia
      • Pakistan
      • Factors Obstructing Improvement of Reproductive Health Status
      • Availability of Contraceptive Products/ Devices
      • The Philippines
    • Table 110: Use of Modern Contraceptive Methods in Philippines: Percentage Use of Select Contraceptive Methods Among Women in Union for the Year 2009 (includes corresponding Graph/Chart)
      • Vietnam
      • AIDS Widely Prevalent in the Country
      • Australia
      • Sri Lanka
      • Malaysia
      • Malaysia to Lead Condom Industry
      • Thailand
      • Sex Education - Need of the Hour
    • Strategic Corporate Developments
    • Product Innovations/Launch
    • Key Player
  • B. Market Analytics
    • Table 111: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 112: Rest of Asia-Pacific Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 113: Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Popular Contraceptives in Latin America and the Caribbean
    • Table 114: Percentage Breakdown of Number of Women in the Age group of 15-49 Years Using Modern Contraceptives in Latin America & the Caribbean by Sub-region (2012) (includes corresponding Graph/Chart)
    • Key USAID Statistics
    • Table 115: USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Percentage Share Breakdown of Value Shipments by Country - Haiti, Peru, Dominican Republic and Others (includes corresponding Graph/Chart)
    • Table 116: USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Percentage Share Breakdown of Value Shipments by Type - Condoms, Implants, Injectables, Orals and IUDs (includes corresponding Graph/Chart)
    • Table 117: USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Breakdown of Value Shipments by Program Type - Parastatal/Governmental, Social Marketing and NGO (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 118: Latin American Recent Past, Current & Future Analysis for Contraceptives by Geographic Region- Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 119: Latin American Historic Review for Contraceptives by Geographic Region - Brazil and Rest of Latin America Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 120: Latin American 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 121: Latin American Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 122: Latin America Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 123: Latin American 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Current and Future Analysis
    • Contraceptives Market Grows Larger by the Day
    • Role of Condom Social Marketing (CSM)
    • New Contraceptive Companies Face Tough Competition
    • Product Innovations/Launch
  • B. Market Analytics
    • Table 124: Brazilian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 125: Brazilian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 126: Brazilian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • A Review of Select Markets
    • Colombia
    • Dominican Republic
    • Table 127: Leading Condom Brands in the Dominican Republic Market (2008): Percentage Breakdown of Market Share for Pante, Durex, Te Amo, Escudo/Protector, Trojan and Others (includes corresponding Graph/Chart)
    • Ecuador
    • Guatemala
    • Mexico
  • B. Market Analytics
    • Table 128: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 129: Rest of Latin America Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 130: Rest of Latin America 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Middle East
      • Socio-Cultural Factors Influencing Use of Condoms
    • Oral Contraceptives Usage Patterns in Near East and Africa
    • Jordan
    • Jamaica
      • Post Offices Playing Key Role in Improving Condom Accessibility
    • Africa
    • Table 131: Percentage Breakdown by Number of Women in the Age Group of 15-49 Years Using Modern Contraceptives in Africa for 2012 by Sub-region (includes corresponding Graph/Chart)
      • High Demand for Condoms in Africa
    • Table 132: USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Country - Malawi, Tanzania, Uganda, Ethiopia, Zimbabwe and Others (includes corresponding Graph/Chart)
    • Table 133: USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Type - Injectables, Male Condoms, Implants, Orals, Female Condoms and IUDs (includes corresponding Graph/Chart)
    • Table 134: USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Program Type -Parastatal/Governmental, Social Marketing and NGO (includes corresponding Graph/Chart)
      • Female Condoms Gain Ground in South Africa
    • Ghana
      • Innovative Marketing Strategies to Drive Growth in the Contraceptives Market
    • Uganda
      • Condoms - A Case of Anti-AIDS Success
    • Kenya
    • Zimbabwe
      • Churches in Dilemma Over Condom Use in Zimbabwe
    • Other Countries
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 135: Rest of World Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 136: Rest of World Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 137: Rest of World 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Show More
Pricing
Get Notified
Email me when related reports are published